Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 7;7(15):e009250.
doi: 10.1161/JAHA.118.009250.

Life Course Trajectories of Cardiovascular Risk Factors in Women With and Without Hypertensive Disorders in First Pregnancy: The HUNT Study in Norway

Affiliations

Life Course Trajectories of Cardiovascular Risk Factors in Women With and Without Hypertensive Disorders in First Pregnancy: The HUNT Study in Norway

Eirin B Haug et al. J Am Heart Assoc. .

Abstract

Background Women with hypertensive pregnancy disorders have adverse levels of cardiovascular risk factors. It is unclear how this adverse risk factor profile evolves during adult life. We compared life course trajectories of cardiovascular risk factors in women with preeclampsia or gestational hypertension in their first pregnancy to normotensive women. Methods and Results We linked information on cardiovascular risk factors from the population-based HUNT (Nord-Trøndelag Health Study) surveys with pregnancy information from the Medical Birth Registry of Norway. Trajectories of cardiovascular risk factors were constructed for 22 308 women with a normotensive first pregnancy; 1092 with preeclampsia, and 478 with gestational hypertension in first pregnancy. Already before first pregnancy, women with preeclampsia in their first pregnancy had higher measures of adiposity, blood pressure, heart rate, and serum lipids and glucose compared with women with a normotensive first pregnancy. After first pregnancy, there was a parallel development in cardiovascular risk factor levels, but women with a normotensive first pregnancy had a time lag of >10 years compared with the preeclampsia group. There were no clear differences in risk factor trajectories between women with gestational hypertension and women with preeclampsia. Conclusions Women with hypertensive pregnancy disorders in their first pregnancy had an adverse cardiovascular risk factor profile before pregnancy compared with normotensive women, and the differences persisted beyond 50 years of age. Hypertensive disorders in pregnancy signal long-term increases in modifiable cardiovascular risk factors, and may be used to identify women who would benefit from early prevention strategies.

Keywords: cardiovascular risk factors; epidemiology; hypertensive disorders of pregnancy; life course.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of study population. HUNT indicates Nord‐Trøndelag Health Study.
Figure 2
Figure 2
Life course trajectories of mean systolic blood pressure (A), diastolic blood pressure (B), BMI (C), waist circumference (D), hip circumference (E), and waist‐to‐hip ratio (F) for women with normotensive and preeclamptic first pregnancies. Estimates are adjusted for age at measurement, HUNT survey, highest obtained education level, age at first birth, and ever daily smoking. Covariates are fixed at their means with gaps in the graphs corresponding to the woman's first pregnancy, birth at age 23 years, and a 3‐month postpartum period. BMI indicates body mass index; CI, confidence interval; HUNT, Nord‐Trøndelag Health Study.
Figure 3
Figure 3
Population average predicted probabilities of hypertension (defined as current antihypertensive medication and/or blood pressure ≥140 mm Hg systolic or ≥90 mm Hg diastolic) (A), obesity (defined as a BMI ≥30 kg/m2) (B), and diabetes mellitus (defined as self‐reported diabetes mellitus, nonfasting serum glucose ≥11.1 mmol/L, fasting serum glucose ≥7.0 mmol/L, and/or 2‐hour postload serum glucose ≥11.1 mmol/L) (C) by age in women with normotensive and preeclamptic first pregnancies. Estimates are adjusted for age at measurement, HUNT survey, highest obtained education level, age at first birth, and ever daily smoking. Covariates are fixed at their means with gaps in the graphs corresponding to the woman's first pregnancy, birth at age 23, and a 3‐month postpartum period. BMI indicates body mass index; CI, confidence interval; HUNT, Nord‐Trøndelag Health Study.
Figure 4
Figure 4
Life course trajectories of mean nonfasting serum non‐HDL (A) and HDL (B) cholesterol, triglycerides (C), and glucose (D), resting heart rate (E), and serum CRP (F) for women with normotensive and preeclamptic first pregnancies. Estimates are adjusted for age at measurement, HUNT survey highest obtained education level, age at first birth and ever daily smoking. Analyses of glucose and triglycerides were additionally adjusted for time since last meal. Covariates are fixed at their means with gaps in the graphs corresponding to the woman's first pregnancy, birth at age 23, and a 3‐month postpartum period. CRP is given as geometric mean. CI indicates confidence interval; CRP, C‐reactive protein; HDL, high‐density lipoprotein; HUNT, Nord‐Trøndelag Health Study.

References

    1. Gholizadeh L, Davidson P. More similarities than differences: an international comparison of CVD mortality and risk factors in women. Health Care Women Int. 2008;29:3–22. - PubMed
    1. American College of Obstetricians and Gynecologists . Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122–1131. - PubMed
    1. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ. 2002;325:157–160. - PMC - PubMed
    1. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd‐Jones DM, Newby LK, Piña IL, Roger VL, Shaw LJ, Zhao D, Beckie TM, Bushnell C, D'Armiento J, Kris‐Etherton PM, Fang J, Ganiats TG, Gomes AS, Gracia CR, Haan CK, Jackson EA, Judelson DR, Kelepouris E, Lavie CJ, Moore A, Nussmeier NA, Ofili E, Oparil S, Ouyang P, Pinn VW, Sherif K, Smith SC, Sopko G, Chandra‐Strobos N, Urbina EM, Vaccarino V, Wenger NK. Effectiveness‐based guidelines for the prevention of cardiovascular disease in women—2011 update. Circulation. 2011;123:1243–1262. - PMC - PubMed
    1. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney M‐T, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen M‐L, Löllgen H, Marques‐Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM; Authors/Task Force Members . 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37:2315–2381. - PMC - PubMed

Publication types

MeSH terms